Terms: = Breast cancer AND ENO2, HEL-S-279, NSE AND Prognosis
15 results:
1. cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.
Guo X; Ma W; Wu H; Xu Y; Wang D; Zhang S; Liu Z; Chekhonin VP; Peltzer K; Zhang J; Wang X; Zhang C
BMC Cancer; 2021 May; 21(1):613. PubMed ID: 34039303
[TBL] [Abstract] [Full Text] [Related]
3. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thezenas S; Jacot W
BMC Cancer; 2016 Jul; 16():428. PubMed ID: 27387327
[TBL] [Abstract] [Full Text] [Related]
4. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.
Watrowski R; Jäger C; Mattern D; Horst C
Anticancer Res; 2012 Nov; 32(11):5079-82. PubMed ID: 23155283
[TBL] [Abstract] [Full Text] [Related]
5. Rhabdomyosarcoma of the breast: a clinicopathologic study and review of the literature.
Li DL; Zhou RJ; Yang WT; Wang J; Yao XH; Cheng YF; Shi DR
Chin Med J (Engl); 2012 Jul; 125(14):2618-22. PubMed ID: 22882949
[TBL] [Abstract] [Full Text] [Related]
6. Granular cell tumour of the breast.
Brown AC; Audisio RA; Regitnig P
Surg Oncol; 2011 Jun; 20(2):97-105. PubMed ID: 20074934
[TBL] [Abstract] [Full Text] [Related]
7. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
[TBL] [Abstract] [Full Text] [Related]
8. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
[TBL] [Abstract] [Full Text] [Related]
9. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
[TBL] [Abstract] [Full Text] [Related]
10. [breast carcinoma in the man. Current results from the viewpoint of clinic and pathology].
Prechtel K; Prechtel V
Pathologe; 1997 Jan; 18(1):45-52. PubMed ID: 9157404
[TBL] [Abstract] [Full Text] [Related]
11. S100 protein positive human breast carcinomas: an immunohistochemical study.
Matsushima S; Mori M; Adachi Y; Matsukuma A; Sugimachi K
J Surg Oncol; 1994 Feb; 55(2):108-13. PubMed ID: 8121183
[TBL] [Abstract] [Full Text] [Related]
12. [Relation between neuroendocrine expression of prostatic carcinoma and prognosis].
Huang ZY; Meng FQ; Chen H
Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):23-5, 62-3. PubMed ID: 8032980
[TBL] [Abstract] [Full Text] [Related]
13. CEA determination in the follow-up of extracolorectal neoplasms.
Lamerz R
Int J Biol Markers; 1992; 7(3):171-8. PubMed ID: 1431341
[TBL] [Abstract] [Full Text] [Related]
14. Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters.
Scopsi L; Andreola S; Pilotti S; Testori A; Baldini MT; Leoni F; Lombardi L; Hutton JC; Shimizu F; Rosa P
Am J Surg Pathol; 1992 Jun; 16(6):561-76. PubMed ID: 1376022
[TBL] [Abstract] [Full Text] [Related]
15. Immunocytochemical reactivity of breast cancer tissue with antibodies to neuron-specific enolase and an adenocarcinoma-associated glycolipid antigen.
Ingelman-Sundberg H; Wikström B; Stormy N; Sundelin P; Hjerpe A
Virchows Arch A Pathol Anat Histopathol; 1989; 415(6):539-44. PubMed ID: 2477947
[TBL] [Abstract] [Full Text] [Related]
